High Tower Advisors, LLC Geron Corp Call Options Transaction History

High Tower Advisors, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 06, 2024	BUY	$1.75 - $3.44 $3,500 - $6,880	2,000 New	2,000 $6,000
Q1 2019 May 15, 2019	SELL	$1.01 - $1.83 $10,100 - $18,300	-10,000 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$1.76 - $6.38 $14,080 - $51,040	8,000 Added 400.0%	10,000 $3,000
Q2 2018 Aug 14, 2018	BUY	$3.29 - $4.82 $6,580 - $9,640	2,000 New	2,000 $2,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.